Liquid Biopsy Market 2018; Splendid Growth at a CAGR of 28% with Topmost Players like Guardant Health, RainDance Technologies, SAGA Diagnostics, etc. – Asserts MRFR

Liquid Biopsy Market 2018 Research Report implements an exhaustive study on Market Research Future. This Report Cover Key Market Driver, market size, growth rate, opportunities, market Dynamics and Overall Analysis. And also cover the other information such as Liquid Biopsy Market trends, Prominent players, chapter-wise Description followed by various user perceptions and Forecast till 2022.

Liquid Biopsy Market - Highlights

Introduction:

Cancer diagnosis and monitoring have now become an important part of the healthcare system. The increasing burden of cancer has led to a need for development of new diagnostic and treatment methods. The researchers are now interested in determining the root cause of various types of cancer such as bone cancer, breast cancer, liver cancer, prostate cancer, and others. Furthermore, there is also need to introduce new diagnostic and treatment options due to increasing prevalence of rare cancer and late diagnosis of the diseases. Late diagnosis thus reduces the chances of curing the disease as it spreads throughout the body.

Liquid biopsy is one of the promising non-invasive method for the diagnosis of cancer. It involves the sampling of tissue in the liquid state. It is a simple and painless method for cancer diagnostic as compared to other diagnostics methods. Therefore, liquid as well as solid biopsy are important for cancer management, and creates excellent growth opportunities in the market. The technology is further applicable for monitoring cardiac and neurologic disease, early detection and evaluation of drug resistance, and prenatal testing. It can now be applied to organ transplant monitoring to bridge the gap between need of new technology, and rising demand.

Get Sample copy @ https://www.marketresearchfuture.com/sample_request/710 .

Driver & Restrains

Increasing awareness about personalized cancer care is ruling the global liquid biopsy market. The market is driven by increasing demand for non-invasive testing, increasing prevalence of cancer, and extensive research and development in the cancer diagnosis and treatment. The market is also driven by number of advantages of liquid biopsies such as quick analysis, identification of specific mutations, low cost, and r less labor required. Furthermore, rising awareness about the diagnosis of various types of cancer stimulate the market growth. However, tumor heterogeneity, remaining the biggest challenge in cancer research, may restrain the growth of the market.

Strategic Approaches by Key Players:

Guardant Health, Inc., Trovagene, Inc., Agena Bioscience Inc. Inc., Admera Health, Biocept, Inc., Circulogene Theranostics, Inivata Ltd., SAGA Diagnostics AB, Exosome Diagnostics, and Bio-Rad Laboratories, Inc., Agena Bioscience Inc. Inc. are major players in the liquids biopsy market. The key players in the market are focusing on the development of new diagnostics methods and tools, as well as various strategic approaches such as acquisitions, partnership, and collaboration. Fund raising for cancer research is one to the important tasks for the key players to development new diagnostics devices and technologies as well as hold their position in the market.

Liquid Biopsy Market - Segmental Analysis

Global Liquid Biopsy market has been segmented on the basis of biomarker type which comprises of circulating tumor cells (Ctcs), circulating tumor DNA (Ctdna), extracellular vesicles (Evs) and other biomarker. On the basis of application; market is segmented into cancer therapeutic application, reproductive health, and other therapeutic application. On the basis of sample; market is segmented into blood, urine and others. On the basis of end-users; market is segmented into hospitals and laboratories, academic and research centers and others.

Get Stunning Discount @ https://www.marketresearchfuture.com/check-discount/710 .

Liquid Biopsy Market - Regional Analysis:

Globally North America is the largest market for Global Liquid Biopsy market. Europe is the second-largest market for Global Liquid Biopsy market. However the developing regions market particularly Asia Pacific will be the fastest growing and will be the key to the future. North America accounted for the largest market share of 37.95% in 2016 accounting for a market value of 1,499.10 million in 2016. Asia pacific is the fastest growing market which is growing at a CAGR of 28.8%.

Cancer Research and Liquid Biopsy:

In February 2016, Circulogene Theranostics entered into a research agreement with the University of Alabama Birmingham (UAB) Comprehensive Cancer Center.

In December 2015, for example, researchers at the San Antonio Breast Cancer Symposium reported the use of cfDNA liquid biopsies to evaluate the prognosis after treatment in breast cancer patients enrolled in two phase III clinical trials.

Additionally, researcher have now successfully applied liquid biopsy to determine the prognosis of patients with colon cancer in phase II. Therefore, increasing applications of liquid biopsy in cancer research is another important driver for the growth of the market.

Major TOC of Global Liquid Biopsy Market Research Report- Forecast to 2022:

1 REPORT PROLOGUE

2 INTRODUCTION

3 RESEARCH METHODOLOGY

4 MARKET DYNAMICS

5 MARKET FACTOR ANALYSIS

6 LIQUID BIOPSY MARKET, BY BIOMARKER TYPES

7 GLOBAL LIQUID BIOPSY MARKET, BY APPLICATION

8 GLOBAL LIQUID BIOPSY MARKET, BY SAMPLE

9 GLOBAL LIQUID BIOPSY MARKET, BY END USER

10 GLOBAL LIQUID BIOPSY MARKET, BY REGION

11 COMPANY PROFILE

List of Tables:

TABLE 1 GLOBAL LIQUID BIOPSY MARKET BY BIOMARKER TYPE, $ MILLION (2016-2022)
TABLE 2 CIRCULATING TUMOR CELLS (CTCS) MARKET, BY REGION, 2014-2022 ($ MILLION)
TABLE 3 CIRCULATING TUMOUR DNA (CTDNA) MARKET, BY REGION, 2014-2022 ($ MILLION)
TABLE 4 EXTRACELLULAR VESICLES (EVS) MARKET, BY REGION, 2014-2022 ($ MILLION)
TABLE 5 OTHER BIOMARKER TYPE MARKET, BY REGION, 2014-2022 ($ MILLION
TABLE 6 GLOBAL LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2014-2022 ($ MILLION)
TABLE 7 CANCER THERAPEUTIC APPLICATION MARKET, BY REGION, 2014-2022 ($ MILLION)
TABLE 8 REPRODUCTIVE HEALTH THERAPEUTIC APPLICATION MARKET, BY REGION, 2014-2022 ($ ILLION)
TABLE 9 OTHER THERAPEUTIC APPLICATION MARKET, BY REGION, 2014-2022 ($ MILLION)
TABLE 10 GLOBAL LIQUID BIOPSY MARKET BY SAMPLE, 2014-2022 ($ MILLION)
TABLE 11 BLOOD SAMPLE MARKET, BY REGION, 2014-2022 ($ MILLION)
TABLE 12 URINE SAMPLE MARKET, BY REGION, 2014-2022 ($ MILLION)
TABLE 13 OTHER SAMPLE MARKET, BY REGION, 2014-2022 ($ MILLION)
TABLE 14 GLOBAL LIQUID BIOPSY MARKET BY END USER, 2014-2022 ($ MILLION)
TABLE 15 HOSPITALS AND LABORATORIES END USERS MARKET, BY REGION, 2014-2022 ($ MILLION)

CONTINUED…

Get Customized Report @ https://www.marketresearchfuture.com/enquiry/710 .

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.